Back

Peptaibiotic-inspired antimicrobials based on human cathelicidin

Albin, J. S.; Vithanage, D. A.; Pentelute, B. L.

2025-05-22 microbiology
10.1101/2025.05.22.655621 bioRxiv
Show abstract

Mammalian cell toxicity is a major barrier to the development amphipathic helical peptides for antibiotic applications. Toward addressing this limitation, we report here the development of a paired Ala-Aib helix scanning approach to isolate the sidechain-independent effects of helical content on the underlying antimicrobial and hemolytic activities of a model cathelicidin-derived scaffold. Despite the generally accepted premise that cathelicidin helical content correlates with antimicrobial activity, we find that this relationship is species-dependent. Moreover, gains in antimicrobial activity associated with greater helical content generally outpace losses associated with increasing hemolytic activity. Combining these insights with our prior work on the development of oligomerization-deficient cathelicidins, we develop a short Aib-rich cathelicidin derivative with a 32-fold improvement in in vitro therapeutic index over the naturally occurring parent helix. Our results thus introduce principles for the rational design of cathelicidin-derived scaffolds based on differential structural requirements for distinct functions.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.